Gabby DeGravina | Investor Relations |
David Dodd | Chairman and Chief Executive Officer |
Mark Reynolds | Chief Financial Officer |
Mark Newman | Chief Scientific Officer |
Kelly McKee | Chief Medical Officer |
John Sharkey | Vice President, Business Development |
Jason Kolbert | Dawson James |
Vernon Bernardino | H.C. Wainwright |
Kumar Raja | Roth Capital |
Robert LeBoyer | Noble Capital Markets |
Good afternoon and welcome everyone to the GeoVax First Quarter 2023 Corporate Update Call. My name is Jack and I will facilitate today’s call. With me are David Dodd, Chairman and CEO; Mark Reynolds, Chief Financial Officer; Mark Newman, PhD, Chief Scientific Officer; Kelly McKee, MD, MPH, Chief Medical Officer; and John Sharkey, PhD, Vice President, Business Development. [Operator Instructions] As a reminder, this conference is being recorded.
At this time, I am turning the call over to Gabby DeGravina of GC Capital.